Pfizer CEO Albert Bourla joined Trump at the White House to sign an agreement on Tuesday, Sept. 30. (Joel Bissell | MLive.com) MLive.com Muskegon Chronicle Joel Bissell | MLive.comKALAMAZOO COUNTY, MI — Pfizer is working with the Trump administration to deliver medicine at a lower cost. It also comes with a $70 billion commitment to U.S. research and development from the pharmaceutical giant. Pfizer’s $70 billion investment will go toward U.S. research, development and capital projects in the next few years, Bourla said. Trump sent letters July 31 to leading pharmaceutical manufacturers outlining steps they must take to bring down prescription drug prices.